ArticlePloS one2014

BikDDA, a mutant of Bik with longer half-life expression protein, can be a novel therapeutic gene for triple-negative breast cancer.

Shiping Jiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.